menu search

RANI / Rani Therapeutics: Novel Drug Delivery System, Under-Covered And Early Stage

Rani Therapeutics: Novel Drug Delivery System, Under-Covered And Early Stage
Rani Therapeutics Holdings, Inc. has an exciting oral drug delivery system for biologics. It has shown excellent early data in trials. Read More
Posted: May 5 2023, 17:33
Author Name: Seeking Alpha
Views: 110536

RANI News  

Rani Therapeutics to Participate in August Investor Conferences

By GlobeNewsWire
August 4, 2023

Rani Therapeutics to Participate in August Investor Conferences

SAN JOSE, Calif., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinica more_horizontal

Rani Therapeutics: Novel Drug Delivery System, Under-Covered And Early Stage

By Seeking Alpha
May 5, 2023

Rani Therapeutics: Novel Drug Delivery System, Under-Covered And Early Stage

Rani Therapeutics Holdings, Inc. has an exciting oral drug delivery system for biologics. It has shown excellent early data in trials. more_horizontal

Rani Therapeutics Holdings, Inc. (RANI) Reports Q3 Loss, Lags Revenue Estimates

By Zacks Investment Research
November 10, 2022

Rani Therapeutics Holdings, Inc. (RANI) Reports Q3 Loss, Lags Revenue Estimates

Rani Therapeutics Holdings, Inc. (RANI) delivered earnings and revenue surprises of 0% and 100%, respectively, for the quarter ended September 2022. D more_horizontal

Rani Therapeutics Holdings, Inc. (RANI) Talat Imran on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
March 29, 2022

Rani Therapeutics Holdings, Inc. (RANI) Talat Imran on Q4 2021 Results - Earnings Call Transcript

Rani Therapeutics Holdings, Inc. (RANI) Talat Imran on Q4 2021 Results - Earnings Call Transcript more_horizontal

Rani Therapeutics to Release Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 29, 2022

By GlobeNewsWire
March 23, 2022

Rani Therapeutics to Release Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 29, 2022

SAN JOSE, Calif., March 23, 2022 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinic more_horizontal


Search within

Pages Search Results: